D. Osborne

Finanzdirektor/CFO bei Melt Pharmaceuticals, Inc.

45 Jahre

Health Technology

Aktive Positionen von D. Osborne

Unternehmen	Position	Beginn	Ende
Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	Finanzdirektor/CFO	01.02.2022	-

Unternehmen	Position	Beginn	Ende
PRECIGEN, INC.	Comptroller/Controller/Auditor	01.04.2016	10.06.2021
	Finanzdirektor/CFO	-	10.06.2021
	Corporate Officer/Principal	01.07.2011	01.04.2016

International

Vereinigte Staaten

Operativ

Director of Finance/CFO	2
Comptroller/Controller/Auditor	1
Corporate Officer/Principal	1

Sektoral

Health Technology

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
PRECIGEN, INC.	Health Technology

Private Unternehmen	1
Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	Health Technology

Private Unternehmen

Health Technology